PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 182 filers reported holding PTC THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,744,955 | -53.4% | 77,865 | -15.4% | 0.00% | 0.0% |
| Q2 2023 | $3,743,714 | +0.6% | 92,051 | +19.8% | 0.00% | 0.0% |
| Q1 2023 | $3,721,258 | -10.4% | 76,822 | -29.4% | 0.00% | -50.0% |
| Q4 2022 | $4,155,492 | +169.1% | 108,868 | +253.9% | 0.00% | +100.0% |
| Q3 2022 | $1,544,000 | -33.3% | 30,761 | -46.8% | 0.00% | 0.0% |
| Q2 2022 | $2,315,000 | -56.3% | 57,792 | -59.3% | 0.00% | -50.0% |
| Q1 2022 | $5,296,000 | +2.6% | 141,969 | +9.5% | 0.00% | +100.0% |
| Q4 2021 | $5,164,000 | +120.9% | 129,672 | +106.4% | 0.00% | 0.0% |
| Q3 2021 | $2,338,000 | +58350.0% | 62,822 | +67450.5% | 0.00% | – |
| Q2 2021 | $4,000 | -99.7% | 93 | -99.7% | 0.00% | -100.0% |
| Q1 2021 | $1,562,000 | -25.1% | 32,972 | -3.5% | 0.00% | 0.0% |
| Q4 2020 | $2,086,000 | +14800.0% | 34,184 | +11527.2% | 0.00% | – |
| Q3 2020 | $14,000 | -94.6% | 294 | -94.2% | 0.00% | – |
| Q2 2020 | $257,000 | -92.0% | 5,063 | -93.0% | 0.00% | -100.0% |
| Q1 2020 | $3,207,000 | +15.6% | 71,889 | +24.5% | 0.00% | +100.0% |
| Q4 2019 | $2,774,000 | -5.3% | 57,749 | -33.3% | 0.00% | 0.0% |
| Q3 2019 | $2,929,000 | +602.4% | 86,606 | +834.6% | 0.00% | – |
| Q2 2019 | $417,000 | +24.9% | 9,267 | +4.6% | 0.00% | – |
| Q1 2019 | $334,000 | -88.3% | 8,856 | -89.4% | 0.00% | -100.0% |
| Q4 2018 | $2,862,000 | +102.3% | 83,397 | +177.1% | 0.00% | 0.0% |
| Q3 2018 | $1,415,000 | +249.4% | 30,099 | +150.6% | 0.00% | – |
| Q2 2018 | $405,000 | +45.2% | 12,011 | +16.6% | 0.00% | – |
| Q1 2018 | $279,000 | -78.0% | 10,298 | -86.4% | 0.00% | -100.0% |
| Q4 2017 | $1,266,000 | -0.7% | 75,863 | +19.1% | 0.00% | 0.0% |
| Q3 2017 | $1,275,000 | +153.5% | 63,713 | +132.2% | 0.00% | – |
| Q2 2017 | $503,000 | -72.1% | 27,436 | -85.0% | 0.00% | -100.0% |
| Q1 2017 | $1,806,000 | +2517.4% | 183,513 | +2792.2% | 0.00% | – |
| Q4 2016 | $69,000 | -46.1% | 6,345 | -30.4% | 0.00% | – |
| Q3 2016 | $128,000 | +113.3% | 9,110 | +6.9% | 0.00% | – |
| Q2 2016 | $60,000 | -79.7% | 8,518 | -81.5% | 0.00% | – |
| Q1 2016 | $296,000 | -97.2% | 46,005 | -85.7% | 0.00% | -100.0% |
| Q4 2015 | $10,444,000 | +3932.4% | 322,331 | +3223.0% | 0.01% | – |
| Q3 2015 | $259,000 | +475.6% | 9,700 | +941.9% | 0.00% | – |
| Q2 2015 | $45,000 | -87.5% | 931 | -84.2% | 0.00% | – |
| Q1 2015 | $359,000 | +372.4% | 5,910 | +303.4% | 0.00% | – |
| Q4 2014 | $76,000 | – | 1,465 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ayer Capital Management, LP | 416,666 | $7,153,000 | 38.92% |
| Novo Holdings A/S | 747,359 | $11,210,000 | 2.78% |
| Bain Capital Public Equity Management, LLC | 2,333,333 | $50,073,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,027 | $18,134,000 | 0.84% |
| HealthCor Management, L.P. | 732,200 | $15,713,000 | 0.84% |
| RA Capital Management | 300,000 | $6,438,000 | 0.67% |
| Catalyst Capital Advisors LLC | 30,666 | $658,000 | 0.36% |
| CR Intrinsic Investors, LLC | 119,237 | $2,559,000 | 0.08% |
| Weiss Multi-Strategy Advisers LLC | 284,130 | $6,098,000 | 0.07% |
| SECTORAL ASSET MANAGEMENT INC | 57,519 | $1,234,000 | 0.06% |